C12N 2830/32
Being an silencer not forming part of the promoter region
Official title: being an silencer not forming part of the promoter region
C12N2830/32 (Being an silencer not forming part of the promoter region) appears on 32 US grants and 35 published applications in this corpus.
Search patents in C12N- Granted patents
- 32
- Published applications
- 35
- Assignees
- 31
- Inventors
- 65
- Latest grant
- 20 Aug 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 6 | 0 |
| 1999 | 5 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 0 |
| 2002 | 0 | 3 |
| 2003 | 2 | 8 |
| 2004 | 0 | 3 |
| 2005 | 2 | 1 |
| 2006 | 0 | 2 |
| 2007 | 0 | 4 |
| 2008 | 0 | 3 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 0 | 1 |
| 2014 | 1 | 0 |
| 2015 | 1 | 2 |
| 2016 | 1 | 2 |
| 2017 | 1 | 1 |
| 2018 | 1 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 2 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 2 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Adeno-associated virus compositions for PAH gene transfer and methods of use thereof20 Aug 2024US 12,064,486 B2Homology Medicines, Inc.
- Adeno-associated virus compositions for PAH gene transfer and methods of use thereof9 Apr 2024US 11,951,183 B2Homology Medicines, Inc.
- Adeno-associated virus compositions for PAH gene transfer and methods of use thereof7 Apr 2020US 10,610,606 B2Homology Medicines, Inc.
- Activity-dependent expression of nucleic acids23 Apr 2019US 10,266,844 B2California Institute of Technology
- Dosage compensating transgenes and cells26 Jun 2018US 10,004,765 B2University of Massachusetts
- Adeno-associated virus compositions for pah gene transfer and methods of use thereof8 Oct 2020US 2020/0316223 A1Homology Medicines, Inc.
- Adeno-associated virus compositions for pah gene transfer and methods of use thereof17 Sep 2020US 2020/0289674 A1Homology Medicines, Inc.
- Adeno-associated virus compositions for pah gene transfer and methods of use thereof1 Aug 2019US 2019/0231901 A1Homology Medicines, Inc.
- Activity-dependent expression of nucleic acids2 Feb 2017US 2017/0029848 A1California Institute of Technology
- Dosage compensating transgenes and cells26 May 2016US 2016/0143951 A1University of Massachusetts
Most cited
By later US patents
- Methods for regulating gene expression170US 5,814,618 ABASF SE · 1998
- Vectors for tissue-specific replication124US 5,998,205 AGenetic Therapy, Inc. · 1999
- Tetracycline regulated transcriptional modulators with altered DNA binding specificities102US 5,589,362 ABASF SE · 1996
- Methods for regulating gene expression39US 6,004,941 ABASF Bioresearch Corporation · 1999
- Mice transgenic for a tetracycline-inducible transcriptional activator31US 5,912,411 AUniversity of Heidelberg · 1999